These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 16109421

  • 1. CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells.
    Bowles JA, Weiner GJ.
    J Immunol Methods; 2005 Sep; 304(1-2):88-99. PubMed ID: 16109421
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of Fc gamma receptor IIIA alpha (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C.
    Borrego F, Lopez-Beltran A, Peña J, Solana R.
    Cell Immunol; 1994 Oct 01; 158(1):208-17. PubMed ID: 8087866
    [Abstract] [Full Text] [Related]

  • 3. Fc gamma RIIIa expression is not increased on natural killer cells expressing the Fc gamma RIIIa-158V allotype.
    Congy-Jolivet N, Bolzec A, Ternant D, Ohresser M, Watier H, Thibault G.
    Cancer Res; 2008 Feb 15; 68(4):976-80. PubMed ID: 18281470
    [Abstract] [Full Text] [Related]

  • 4. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
    van de Griend RJ, Bolhuis RL, Stoter G, Roozemond RC.
    J Immunol; 1987 May 15; 138(10):3137-44. PubMed ID: 2952709
    [Abstract] [Full Text] [Related]

  • 5. Activation of cloned human natural killer cells via Fc gamma RIII.
    Werfel T, Uciechowski P, Tetteroo PA, Kurrle R, Deicher H, Schmidt RE.
    J Immunol; 1989 Feb 15; 142(4):1102-6. PubMed ID: 2464637
    [Abstract] [Full Text] [Related]

  • 6. Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab.
    Bowles JA, Wang SY, Link BK, Allan B, Beuerlein G, Campbell MA, Marquis D, Ondek B, Wooldridge JE, Smith BJ, Breitmeyer JB, Weiner GJ.
    Blood; 2006 Oct 15; 108(8):2648-54. PubMed ID: 16825493
    [Abstract] [Full Text] [Related]

  • 7. Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies.
    Galatiuc C, Gherman M, Metes D, Sulica A, DeLeo A, Whiteside TL, Herberman RB.
    Cell Immunol; 1995 Jul 15; 163(2):167-77. PubMed ID: 7606790
    [Abstract] [Full Text] [Related]

  • 8. MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: role of endogenously secreted TNF-alpha.
    Jewett A, Bonavida B.
    Clin Immunol; 2000 Jul 15; 96(1):19-28. PubMed ID: 10873424
    [Abstract] [Full Text] [Related]

  • 9. Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: the FcR gamma III (CD16) molecule and NK cell differentiation.
    Warren HS, Skipsey LJ.
    Immunology; 1991 Jan 15; 72(1):150-7. PubMed ID: 1825480
    [Abstract] [Full Text] [Related]

  • 10. Expression and function of Fc gamma RII on human natural killer cells.
    Metes D, Galatiuc C, Moldovan I, Morel PA, Chambers WH, DeLeo AB, Rabinowich H, Schall R, Whiteside TL, Sulica A.
    Nat Immun; 1994 Jan 15; 13(6):289-300. PubMed ID: 7894200
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X, Zhang L, Solomon GF, Bonavida B.
    Brain Behav Immun; 2002 Jun 15; 16(3):227-46. PubMed ID: 12009684
    [Abstract] [Full Text] [Related]

  • 12. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.
    Dall'Ozzo S, Tartas S, Paintaud G, Cartron G, Colombat P, Bardos P, Watier H, Thibault G.
    Cancer Res; 2004 Jul 01; 64(13):4664-9. PubMed ID: 15231679
    [Abstract] [Full Text] [Related]

  • 13. Quantitative analysis of the effect of CD16 ligation on human NK cell proliferation.
    Warren HS, Kinnear BF.
    J Immunol; 1999 Jan 15; 162(2):735-42. PubMed ID: 9916693
    [Abstract] [Full Text] [Related]

  • 14. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E, Alvarez E, Cantó E, Vidal S, Rodríguez-Sánchez JL, Sierra J, Briones J.
    Exp Hematol; 2008 Jan 15; 36(1):69-77. PubMed ID: 17959301
    [Abstract] [Full Text] [Related]

  • 15. The regulatory role of CD45 on rat NK cells in target cell lysis.
    Giezeman-Smits KM, Gorter A, van Vlierberghe RL, v Eendenburg JD, Eggermont AM, Fleuren GJ, Kuppen PJ.
    J Immunol; 1999 Jul 01; 163(1):71-6. PubMed ID: 10384101
    [Abstract] [Full Text] [Related]

  • 16. The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.
    Fischer L, Penack O, Gentilini C, Nogai A, Muessig A, Thiel E, Uharek L.
    Exp Hematol; 2006 Jun 01; 34(6):753-9. PubMed ID: 16728280
    [Abstract] [Full Text] [Related]

  • 17. Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells.
    Cecchetti S, Spadaro F, Lugini L, Podo F, Ramoni C.
    Eur J Immunol; 2007 Oct 01; 37(10):2912-22. PubMed ID: 17899539
    [Abstract] [Full Text] [Related]

  • 18. Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive natural killer cells.
    Jewett A, Cacalano NA, Head C, Teruel A.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):1994-2003. PubMed ID: 16609008
    [Abstract] [Full Text] [Related]

  • 19. NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement.
    Wang SY, Racila E, Taylor RP, Weiner GJ.
    Blood; 2008 Feb 01; 111(3):1456-63. PubMed ID: 18024795
    [Abstract] [Full Text] [Related]

  • 20. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes.
    Lanier LL, Ruitenberg JJ, Phillips JH.
    J Immunol; 1988 Nov 15; 141(10):3478-85. PubMed ID: 2903193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.